These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37148981)

  • 21. Age-related changes in ultrastructural features of cathepsin B- and D-containing neurons in rat cerebral cortex.
    Jung H; Lee EY; Lee SI
    Brain Res; 1999 Oct; 844(1-2):43-54. PubMed ID: 10536260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors.
    Xu H; Bao K; Tang S; Ai J; Hu H; Zhang W
    J Pept Sci; 2017 Sep; 23(9):701-706. PubMed ID: 28585417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
    Sohar N; Hammer H; Sohar I
    Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: mediated by the mannose-6-phosphate/IGF-II receptor?
    Dabrosin C; Johansson AC; Ollinger K
    Breast Cancer Res Treat; 2004 Jun; 85(3):229-38. PubMed ID: 15111761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catalytically inactive human cathepsin D triggers fibroblast invasive growth.
    Laurent-Matha V; Maruani-Herrmann S; Prébois C; Beaujouin M; Glondu M; Noël A; Alvarez-Gonzalez ML; Blacher S; Coopman P; Baghdiguian S; Gilles C; Loncarek J; Freiss G; Vignon F; Liaudet-Coopman E
    J Cell Biol; 2005 Jan; 168(3):489-99. PubMed ID: 15668295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory cytokines increase extracellular procathepsin D in permanent and primary endothelial cell cultures.
    Erdmann S; Ricken A; Hummitzsch K; Merkwitz C; Schliebe N; Gaunitz F; Strotmann R; Spanel-Borowski K
    Eur J Cell Biol; 2008 May; 87(5):311-23. PubMed ID: 18387691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability.
    Li Z; Li H; Jiang F; Wang Z; Zhang W
    Bioorg Med Chem; 2022 Mar; 57():116646. PubMed ID: 35121401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin H deficiency in mice induces excess Th1 cell activation and early-onset of EAE though impairment of toll-like receptor 3 cascade.
    Okada R; Zhang X; Harada Y; Wu Z; Nakanishi H
    Inflamm Res; 2018 May; 67(5):371-374. PubMed ID: 29470604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.
    Ashraf Y; Mansouri H; Laurent-Matha V; Alcaraz LB; Roger P; Guiu S; Derocq D; Robin G; Michaud HA; Delpech H; Jarlier M; Pugnière M; Robert B; Puel A; Martin L; Landomiel F; Bourquard T; Achour O; Fruitier-Arnaudin I; Pichard A; Deshayes E; Turtoi A; Poupon A; Simony-Lafontaine J; Boissière-Michot F; Pirot N; Bernex F; Jacot W; du Manoir S; Theillet C; Pouget JP; Navarro-Teulon I; Bonnefoy N; Pèlegrin A; Chardès T; Martineau P; Liaudet-Coopman E
    J Immunother Cancer; 2019 Feb; 7(1):29. PubMed ID: 30717773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment.
    Maynadier M; Farnoud R; Lamy PJ; Laurent-Matha V; Garcia M; Rochefort H
    Int J Oncol; 2013 Nov; 43(5):1683-90. PubMed ID: 24026424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis.
    Derocq D; Prébois C; Beaujouin M; Laurent-Matha V; Pattingre S; Smith GK; Liaudet-Coopman E
    Oncogene; 2012 Jun; 31(26):3202-12. PubMed ID: 22081071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
    Werle B; Jülke B; Lah T; Spiess E; Ebert W
    Br J Cancer; 1997; 75(8):1137-43. PubMed ID: 9099961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis.
    Srivastava M; Steinwede K; Kiviranta R; Morko J; Hoymann HG; Länger F; Buhling F; Welte T; Maus UA
    Respir Res; 2008 Jul; 9(1):54. PubMed ID: 18638383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous cell carcinoma of the vulva. Expression of tumor proteases cathepsin-D and pro-cathepsin-L.
    Hantschmann P; Beysiegel S; Kurzl R
    J Reprod Med; 1998 Nov; 43(11):933-42. PubMed ID: 9839260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cathepsin V: Molecular characteristics and significance in health and disease.
    Lecaille F; Chazeirat T; Saidi A; Lalmanach G
    Mol Aspects Med; 2022 Dec; 88():101086. PubMed ID: 35305807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual role of cathepsin D: ligand and protease.
    Fusek M; Vetvicka V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):43-50. PubMed ID: 16170387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cathepsin D and its prognostic value in neuroepithelial brain tumors.
    Pigac B; Dmitrović B; Marić S; Masić S
    Coll Antropol; 2012 Mar; 36(1):227-33. PubMed ID: 22816225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysosomal membrane permeabilization is involved in curcumin-induced apoptosis of A549 lung carcinoma cells.
    Chen QY; Shi JG; Yao QH; Jiao DM; Wang YY; Hu HZ; Wu YQ; Song J; Yan J; Wu LJ
    Mol Cell Biochem; 2012 Jan; 359(1-2):389-98. PubMed ID: 21874542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of the estrogen-regulated proteins, cathepsin-D and pS2, in breast cancer.
    Fulco RA; Petix M; Salimbeni V; Torre EA
    Minerva Med; 1998; 89(1-2):5-10. PubMed ID: 9561019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosis.
    Maurizi M; Almadori G; Cadoni G; Scambia G; Ottaviani F; Ferrandina G; Paludetti G; D'Abramo G; Mancuso S
    Int J Cancer; 1996 Apr; 69(2):105-9. PubMed ID: 8608976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.